Welcome : Guest
  • Only Report Titles
  • Titles & Keywords

IMAGING AGENTS - A GLOBAL STRATEGIC BUSINESS REPORT   

Research Abstract

This report analyzes the worldwide markets for Imaging Agents in US$ Million by the following product segments - Contrast Media (X-Ray, MRI, & Ultrasound), and Diagnostic Radiopharmaceuticals. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East, and Latin America. Annual estimates and forecasts are provided for each region for the period 2007 through 2015. Also, a seven-year historic analysis is provided for these markets. The report profiles 55 companies including many key and niche players such as AMAG Pharmaceuticals Inc., Bayer Schering Pharma AG, Bracco Group, Covidien, Cytogen Corp., Daiichi Sankyo Company Limited, Eisai Co., Ltd, GE Healthcare, Guerbet Group, and Lantheus Medical Imaging. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

Code : MCP-3336
Price : $4500
Companies : 55
Pages : 449
Date : February 2011
Market Data Tables : 71

Complimentary Copy of Study Findings:


Request a Complimentary Copy of the Study’s Key Findings, Drivers, Trends, Program Sources, and Methodology.
Salutation:
First Name:
Last Name:
Email ID: (Domain Specific Email Required)
Company:
NOTE: Generic Email IDs such as AOL, Hotmail, Yahoo, Gmail, MSN etc. cannot be used

 TABLE OF CONTENTS

  IMAGING AGENTS (Complete Report) Pages : 449   | $4500
 
  1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS.......14 $295  
   Study Reliability and Reporting Limitations.......1  
   Disclaimers.......2  
   Data Interpretation & Reporting Level.......3
Quantitative Techniques & Analytics.......3
Product Definitions and Scope of Study.......3
A. Contrast Media.......3
X-Ray Contrast Media.......3
  
   Magnetic Resonance Imaging (MRI) Contrast Media.......4
Ultrasound Contrast Media.......4
B. Diagnostic Radiopharmaceuticals.......4
  
  2. INDUSTRY OVERVIEW.......613 $950  
   Medical Imaging Industry Under the Impact of Economic Downturn.......6
Future Prospects.......6
2$200
   Targeted MRI Imaging – A Game Changer in the Making?.......8
Developing Countries to Spur Growth.......8
A Quick Primer On Imaging Agents.......8
1$100
   Growth Drivers.......91$100
   Growth Inhibitors.......101$100
   Changing Dynamics of Imaging Agents.......111$100
   Imaging Agents: Significant Growth Ahead.......12
Rise of Non-Ionizing Imaging Techniques.......12
1$100
   Fusion Imaging Modalities: Greater Clinical Benefits.......13
Radioactive Isotopes Utilized in PET & SPECT Imaging Procedures.......13
1$100
   Radiopharmaceuticals-An Exotic Tool.......14
Nanomaterials Taking the Center Stage.......14
1$100
   Gadolinium Coated Nanoparticles- A Promising Imaging Agent.......15
A Peek Into Pricing Dynamics.......15
A Synoptic Overview.......15
1$100
   Pros & Cons.......16
Positive Factors Driving Prices.......16
Negative Factors Bearing Down on Prices.......16
1$100
   Reimbursements.......17
“Under the Umbrella”.......17
Europe.......17
United States.......17
2$200
  3. MARKET TRENDS & ISSUES.......194 $295  
   Falling Prices Turn On the Heat.......19
X-Ray Contrast Media: Declining Sector.......19
MRI Contrast Media: Playing at Center Court.......19
Impact Wielded by Ballooning MRI Practices.......19
1$100
   Ultrasound Contrast Media: A Rising Star in the Quadrant.......201$100
   Fledging Market Battles Teething Challenges.......21
PET: A Prime Growth Driver for Radiopharmaceuticals.......21
1$100
   Nuclear Medicine: A Potential Growth Avenue for Radiopharmaceuticals.......22
Select Cardiology and Oncology Radiopharmaceuticals.......22
1$100
  4. COMPETITION.......234 $595  
   Market Structure.......231$100
   Big Guns in the Emerging MRI Market.......24
Bayer Schering Pharma AG: A Pioneering Developer of MRI Contrast Agents.......24
1$100
   Competitive Scenario.......25
Table 1: Worldwide Imaging Agents Market (2009E): Percentage Breakdown of Value Sales for Leading Players- GE Healthcare, Bracco, Covidien, Bayer Schering Pharma, and Others (includes corresponding Graph/Chart).......25

Table 2: X-ray Medical Contrast Media Market Worldwide (2009E): Percentage Breakdown of Sales for GE Healthcare, Bracco, Covidien, Bayer Schering Pharma and Others (includes corresponding Graph/Chart).......25
1$350
   Table 3: MRI Contrast Media Market Worldwide (2009): Percentage Breakdown of Sales for Bayer Schering Pharma, GE Healthcare, Bracco, Covidien and Others (includes corresponding Graph/Chart).......26

Table 4: Radiopharmaceutical Contrast Media Market Worldwide: Percentage Share of Leading Players for 2007 – GE Healthcare, Bristol-Myers Squibb, Mallinckrodt/ Covidien, MDS Nordion and Others (Revenue Share) (includes corresponding Graph/Chart).......26
1$350
  5. TECHNOLOGY BREAKTHROUGHS.......273 $295  
   Molecular Imaging Agents: The Outer Limits.......27
On Cards: Hyperpolarized Gases as Contrast Agents.......27
1$100
   Imaging Agents Make a Welcome Impact in the Field of Alzheimer’s Disease.......28
Technetium-99m: A Breakthrough Contrast Agent for CNS Imaging.......28
A New Imaging Agent for Radiopharmaceutical Scans.......28
Multi-Modal Image Registration: Combating Contrast Medium Inconsistencies.......28
1$100
   Saline Flushes To Help Ensure Accurate Delivery of Contrast Agents.......291$100
  6. PRODUCT OVERVIEW.......3013 $1450  
   Contrast Agents.......30
Contrast Media: How Do They Function?.......30
1$100
   Where Are They Used ?.......31
Evolution of Contrast Media: A Profile.......31
Bismuth Nitrate: Beginning of Contrast Agents.......31
1$100
   Imaging Agents: Significant Developments in the Last Fifty Years.......32
Schering Develops First Intravenous Contrast Agent.......32
MRI: Creating a New Era for Contrast Agents.......32
A Peek into the Finer Points of Differences Among Contrast Media.......32
Viscosity.......32
1$100
   Osmolality.......33
Chemotoxicity.......33
Second Generation Non-Ionic Contrast Agents: An Introduction.......33
Choice of the Contrast Medium: A Weighty Decision.......33
Factors affecting choice of Imaging Agents.......33
1$100
   Taxonomy.......34
Types of Contrast Media.......34
X-Ray Contrast Medium.......34
1$100
   First Generation High Osmolar Contrast Media.......35
Second Generation Low Osmolar Contrast Media or LOCM.......35
Table 5: Comparative Analysis of Structure of Non-ionic and ionic X-ray Contrast Media.......35
MRI Contrast Medium.......35
2$700
   Role of Contrast Enhancement in MR Angiography (MRA).......37
MRI Contrast Agents for the Liver.......37
Paramagnetic extracellular contrast agents.......37
Hepatobiliary Gadolinium Chelates.......37
Superparamagnetic Iron Oxide Particles.......37
Ultrasound Contrast Medium.......37
1$100
   Ultrasonographic Contrast Media: What Are They?.......381$100
   Ultrasound Contrast Enhancement in Cardiology.......39
Functionalities of Vascular Ultrasound Contrast Agents.......39
Diagnostic Radiopharmaceuticals.......39
1$100
   Key Radioactive Isotopes used as Diagnostic Radiopharmaceuticals.......401$100
   A Delineate of Diagnostic Radiopharmaceuticals.......41
Diagnostic Radiopharmaceuticals: A Technical Run-Through.......41
1$100
   Applications.......421$100
  7. A SEGMENTAL REVIEW.......435 $395  
   Contrast Media.......43
Popular Brands of Contrast Agents.......43
1$100
   X-ray Contrast Media.......44
Market Scenario.......44
1$100
   MRI Contrast Media.......451$100
   Market Scenario.......441$100
   Ultrasound Contrast Media.......45
Market Overview.......45
1$100
   Competitive Scenario.......46
Diagnostic Radiopharmaceuticals.......46
Market Overview.......46
Immunoconjugates.......46
Market Overview.......46
1$100
   Competitive Scenario.......471$100
  8. TECHNOLOGY DYNAMICS.......485 $395  
   Proprietary Technologies Making Significant In-Roads.......48
Advanced Magnetics’ Proprietary Colloidal Superparamagnetic Particle
  Technology.......48
Enzon’s Single Chain Antigen-Binding Technology.......48
Immunomedics’ Antibody Technology.......48
First Generation.......48
Second Generation.......48
Third Generation.......48
1$100
   NeoRx’s “Painting the Target” Technology.......49
Stage - I.......49
Stage - II.......49
Stage - III.......49
Gas Encapsulation Technology for Ultrasound Contrast Media.......49
1$100
   Pharmacyclics’ Texaphyrin Technology.......50
Regulatory Bodies.......50
Ultrasound Contrast Agents Are Drugs, Not Devices - Rules US FDA.......50
Entry Barriers.......50
Research Driven Markets.......50
1$100
   Highly Competitive Market.......51
Economies of Scale.......51
Substitutes in Agents Manufacturing.......51
New X-ray Diagnostic Agents.......51
Amide-based Macrocyclic Ligands - Potential MRI Agents.......51
Gadolinium (III) Complexes - Potential MRI Contrast Agents.......51
Metal-Containing Compounds Act As Potential Contrast Agents.......51
Therapeutic Applications.......51
1$100
   Diagnostic Applications.......52
Magnetic Gels as Potential MRI Contrast Agents.......52
PFCs as Diagnostic Contrast Agents.......52
1$100
  9. PRODUCT LAUNCHES.......539 $595  
   GE Healthcare Receives FDA Approval for DaTscan for detecting Dopamine
  Transporters.......53
Targeson Launches Targestar® P-HF.......53
GE Healthcare Announces Phase II Study Results of Flutemetamol, the PET Imaging Agent
  for Brain Imaging.......53
GE Healthcare Receives FDA Approval for Cysview, An Optical Imaging Agent for
  Cystoscopic Detection of Papillary Bladder Cancer.......53
1$100
   INER Develops Imaging Agents for Cerebral Blood Flow.......54
Lantheus Medical Imaging Introduces Definity Ultrasound Contrast Imaging Agent in
  India.......54
Sanochemia Pharmazeutika Completes DCP Phase of MRT Imaging Agent, to Introduce
  Within Major European Markets by 2011.......54
Bayer Transfers Liver MRI Contrast Medium Resovist Injection to I’rom
  Pharmaceutical.......54
GE Healthcare Re-Introduces Contrast Agent, OptisonTM.......54
1$100
   Lantheus Medical Imaging Introduces ABLAVAR™ in Canada.......55
VisEn Introduces ProSense® 750 FAST and Neutrophil ElastaseTM 680 FAST.......55
Bayer Works on Development of MR Contrast Agents for Breast Cancer Diagnosis.......55
1$100
   Lantheus Medical Imaging Introduces ABLAVAR™ MRA Imaging Agent.......56
VisEn Introduces Cat B 680 FAST™ Imaging Agent.......56
VisEn Medical Introduces GastroSense 750 Fluorescence Imaging Agent.......56
1$100
   VisEn Medical Unveils VivoTag® 645 Red Fluorescent Dye.......57
VisEn Medical Launches VivoTag® 680 XL Fluorescent Dye.......57
AMAG Pharmaceuticals Unveils Superparamagnetic Iron Oxide Nanopaticles.......57
MabCure Unveils Monoclonal Antibodies.......57
1$100
   VisEn Medical Introduces ReninSense680TM FAST.......58
VisEn Medical Introduces New VivoTag® 800 and OsteoSense® Imaging Agents.......58
VisEn Medical Introduces Annexin-Vivo 750 Imaging Agent.......58
1$100
   VisEn Introduces New Fluorescence Molecular Imaging Agent, IntegriSense™ 750.......59
Bayer to Launch Primovist™ and Nexavar™ in Japan.......59
1$100
   Sanochemia Unveils MR-Lux®.......60
VisEn Medical Introduces New Fluorescence in Vivo Imaging Agent, IntegriSense.......60
1$100
   Bayer to Unleash Radiology Management System.......61
Bayer to Unveil Pre-Filled Contrast-Medium Cartridges for MRI.......61
1$100
  10. RECENT INDUSTRY ACTIVITY.......6217 $950  
   University of Montana Receives Patents for Two New Brain Imaging Agents.......62
Eli Lilly Acquires Avid Radiopharmaceuticals.......62
GE Global Research Secures Multi-Year NIH Grant to Develop Nerve Imaging Agent and
  Imaging System.......62
Agfa Healthcare Snaps Insight Agents.......62
1$100
   Nordion to Divest MDS Nordion S.A........63
Sofie Biosciences Secures Funds for Research on Molecular PET Imaging Agents.......63
Aposense Signs Collaboration Agreement With Roche.......63
University of Washington to Collaborate with Cardinal Health for Advancement of
  Molecular Imaging.......63
1$100
   ImaginAb Joins Hand with GE Imanet for Developmental Drug Research.......64
Cancer Targeted Technology Inks Agreement with Bayer Pharma for Cancer PET Imaging
  Agent.......64
Lantheus Medical Imaging Wins Global Rights for Gadofosveset Trisodium.......64
Avid Radiopharmaceuticals Partners with Siemens PETNET Solutions for Production of
  Florbetapir F 18.......64
1$100
   VisEn Expands Fluorescence Imaging Intellectual Patent Portfolio through Acquisition of
  Bayer Schering’s Portfolio.......65
Cardinal Health Enters into Partnership with ProVision for Cyclotrons.......65
Center for Diagnostic Imaging Sets up New Imaging Center.......65
ImaginAb Signs Sub Licensing Agreement for huJ591 with BZL Biologics.......65
1$100
   Lantheus Medical Imaging and NTP Radioisotopes Sign Agreement for
  Molybdenum-99.......66
Lantheus Medical Imaging Purchases MS-325 Related Rights from EPIX
  Pharmaceuticals.......66
GE Healthcare Inks Agreement with Nycomed.......66
Photocure Secures Reimbursement Approval for Hexvix in Germany.......66
1$100
   Agfa HealthCare to Acquire Insight Agents.......67
Eckert & Ziegler Disinvests FCI Contrast Media Business.......67
1$100
   Guerbet Signs Distribution Agreement with Draximage for its Nuclear Medicine Product
  Range.......68
ImaginAb Signs Sub Licensing Agreement for huJ591 with BZL Biologics.......68
Lantheus Medical Imaging and NTP Radioisotopes Sign Agreement for
  Molybdenum-99.......68
1$100
   Lantheus Medical Imaging Purchases MS-325 Related Rights for Select Markets from EPIX
  Pharmaceuticals.......69
MDS Nordion, TRIUMF and University of British Columbia Enter into Partnership.......69
Alseres Pharmaceuticals Signs Agreement for Special Protocol Assessment of
  Altropane.......69
1$100
   Pharmalucence Wins Approval from FDA for Sestamibi Kit.......70
Covidien Obtains Approval from Health Canada for Sestamibi Injection.......70
MDS Nordion Commences Production of CardioGen-82.......70
Avista Capital Partners Acquires Bristol-Myers Squibb Medical Imaging.......70
1$100
   Amerinet Awards Contract to Bayer HealthCare.......71
Bristol-Myers Squibb Medical Imaging Changes Name to Lantheus Medical Imaging.......71
1$100
   Bayer Schering Secures FDA Marketing Clearance for Primovist®.......72
Bracco-Eisai Secures Approval for Iomeron® 350 and Iomeron® 350 Syringe for Use in
  Dynamic Liver CT.......72
1$100
   Covidien Signs Co-Marketing Deal with PETNET over Nuclear Medicine Therapies.......731$100
   EPIX Receives FDA Approval for Vasovist.......74
GE Global and NCI Partner to Speed-up Development of Cancer and Heart Disease
  Diagnosing Nanoparticle Imaging Agents.......74
1$100
   Lantheus Wins Contract from PPP.......75
Sanguine to Take over Rockland.......75
Starpharma Holdings Enters into an Agreement with Unilever.......75
GE Healthcare and Cardinal Health Enter Into a Deal.......75
1$100
   Jubilant to Take Over DRAXIS.......76
MTTI and Bexion to Partner for Nanovesicle.......76
Otsuka Takes over IPP.......76
1$100
   Wilex Inks Deal with IBA.......77
Cytogen Corporation to Merge Business with EUSA Pharma Inc.......77
Bracco Group Acquires E-Z-EM.......77
EPIX Pharmaceuticals to Resubmit New Drug Application (NDA) for Vasovist.......77
1$100
   Bayer Schering, FutureChem Ink Licensing Deal.......78
NuView Radio Pharmaceuticals Inks Agreement for Non- Invasive Imaging Agent.......78
1$100
  11. CORPORATE ACTIVITY IN RECENT PAST – A PERSPECTIVE BUILDER.......795 $395  
   Advanced Magnetics Inc Changes Name to AMAG Pharmaceuticals.......79
Bracco Diagnostics Inks Agreement with HealthTrust Purchasing Group.......79
Bracco Diagnostics Offers MRI Products to HealthTrust Purchasing Group.......79
Bayer HealthCare Offers MRI Contrast Agent to HealthTrust.......79
Bayer HealthCare Extends Contract with Premier.......79
Bayer HealthCare Sets Off US Operations.......79
1$100
   Tyco Healthcare Renamed to Covidien Ltd.......80
Covidien Offers Imaging Solutions to MedAssets Supply Chain Systems.......80
Siemens, M.D. Anderson Cancer Center Set up Research Centre.......80
Bayer, Berlex Merge Operations.......80
AION Diagnostics Forays Pre-Clinical Imaging Agent Market.......80
ART Acquires Alerion Biomedical.......80
1$100
   EPIX to Merge with Predix.......81
Fujifilm Acquires Stake in Daiichi Radioisotope Laboratories.......81
Bracco Diagnostics Inks Agreement with Amerinet.......81
Vasovist receives Green Signal in Australia.......81
AION Diagnostics Develops BioSilicon TM.......81
Sonazoid Receives Import Approval.......81
1$100
   Schering AG Divests Radiopharmaceutical Business to Ion Beam Applications and Institut
  National des Radioéléments.......82
Vasovist Receives European Approval.......82
Albany Molecular Research Renews Supply Agreement with GE Healthcare.......82
QuantRx Biomedical Corp. Acquires Stake in FluoroPharma.......82
Palatin Technologies Withdraws NeutroSpec Imaging Agent.......82
1$100
   Diosynth Bags Contract to Produce Imaging Agent.......83
GE Healthcare Signs Marketing Agreement with PhotoCure.......83
DRAXIMAGE Receives the Green Signal in Europe.......83
Daiichi and Sankyo Sign a Merger Deal.......83
1$100
  12. PRODUCT INTRODUCTIONS IN RECENT PAST – A PERSPECTIVE BUILDER.......84   
   Insight Agents to Launch Generic Contrast Media Solutions In Europe.......84
Researchers Develop First Biocompatible MRI Contrast Agent.......84
Signalomics and Invitrogen Collaborate to Develop Nanocrystal Reagents.......84
Schering AG Collaborates with Stanford University to Develop Molecular Imaging
  Agent.......84
Schering and Avid to Develop Diagnostic Imaging Agents.......84
1$100
   US National Institutes of Health Develops two PET Imaging Agents.......851$100
  13. FOCUS ON SELECT PLAYERS.......864 $295  
   AMAG Pharmaceuticals, Inc. (USA).......86
Bayer Schering Pharma AG (Germany).......86
Bracco Group (Italy).......86
1$100
   Covidien (USA).......87
Cytogen Corp. (USA).......87
1$100
   Daiichi Sankyo Company Limited (Japan).......88
Eisai Co Ltd. (Japan).......88
GE Healthcare (UK).......88
1$100
   Guerbet Group (France).......89
Lantheus Medical Imaging (USA).......89
1$100
  14. GLOBAL MARKET PERSPECTIVE.......90   
   Table 6: World Recent Past, Current & Future Analysis for Imaging Agents by Geographic Region - US, Canada, Japan, Europe, Asia–Pacific (excluding Japan), Middle East and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......901$350
   Table 7: World Historic Review for Imaging Agents by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).......911$350
   Table 8: World 11-Year Perspective for Imaging Agents by Geographic Region- Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia–Pacific (excluding Japan), Middle East and Latin America Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).......921$350
   Table 9: World Recent Past, Current & Future Analysis for Contrast Media by Geographic Region - US, Canada, Japan, Europe, Asia–Pacific (excluding Japan), Middle East and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......931$350
   Table 10: World Historic Review for Contrast Media by Geographic Region – US, Canada, Japan, Europe, Asia- Pacific (excluding Japan), Middle East and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).......941$350
   Table 11: World 11-Year Perspective for Contrast Media by Geographic Region- Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia–Pacific (excluding Japan), Middle East and Latin America Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).......951$350
   Table 12: World Recent Past, Current & Future Analysis for Contrast Media by Product Segments – X-Ray, MRI and Ultrasound Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......961$350
   Table 13: World Historic Review for Contrast Media by Product Segments – X-Ray, MRI and Ultrasound Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).......97

Table 14: World 11-Year Perspective for Contrast Media by Product Segments - Percentage Breakdown of Dollar Sales for X-Ray, MRI and Ultrasound Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).......97
1$350
   Table 15: World Recent Past, Current & Future Analysis for X-Ray Contrast Media by Geographic Region - US, Canada, Japan, Europe, Asia–Pacific (excluding Japan), Middle East and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......981$350
   Table 16: World Historic Review for X-ray Contrast Media by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).......991$350
   Table 17: World 11-Year Perspective for X-Ray Contrast Media by Geographic Region- Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia–Pacific (excluding Japan), Middle East and Latin America Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).......1001$350
   Table 18: World Recent Past, Current & Future Analysis for MRI Contrast Media by Geographic Region - US, Canada, Japan, Europe, Asia–Pacific (excluding Japan), Middle East and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......1011$350
   Table 19: World Historic Review for MRI Contrast Media by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).......1021$350
   Table 20: World 11-Year Perspective for MRI Contrast Media by Geographic Region- Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia–Pacific (excluding Japan), Middle East and Latin America Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).......1031$350
   Table 21: World Recent Past, Current & Future Analysis for Ultrasound Contrast Media by Geographic Region - US, Canada, Japan, Europe, Asia–Pacific (excluding Japan), Middle East and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......1041$350
   Table 22: World Historic Review for Ultrasound Contrast Media by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).......1051$350
   Table 23: World 11-Year Perspective for Ultrasound Contrast Media by Geographic Region- Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia–Pacific (excluding Japan), Middle East and Latin America Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).......1061$350
   Table 24: World Recent Past, Current & Future Analysis for Diagnostic Radiopharmaceuticals by Geographic Region - US, Canada, Japan, Europe, Asia–Pacific (excluding Japan), Middle East and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......1071$350
   Table 25: World Historic Review for Diagnostic Radiopharmaceuticals by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).......1081$350
   Table 26: World 11-Year Perspective for Diagnostic Radiopharmaceuticals by Geographic Region- Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia–Pacific (excluding Japan), Middle East and Latin America Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).......1091$350
  15. THE UNITED STATES.......11010 $1450  
   A. Market Analysis.......110
Outlook.......110
Imaging Centers Feel the Heat During Recession.......110
1$100
   Growth Stimulants.......111
Dynamics of Pricing.......111
1$100
   Diagnostic Radiopharmaceuticals.......112
Market Scenario.......112
Availability of Isotopes: A Tough Challenge.......112
Radiopharmaceuticals to Drive Growth.......112
1$100
   Competitive Analysis – Imaging Market.......113
Reimbursement Issues.......113
Medicare.......113
1$100
   Magnetic Resonance Imaging.......1141$100
   Regulatory Environment.......1151$100
   Provisions Regarding Off-Label Usage of Contrast Media.......116
Contrast Media.......116
X-ray Contrast Media.......116
MRI Contrast Media.......116
Market Scenario.......116
1$100
   Managed Care Vs MRI Technology Diffusion.......117
Ultrasound Contrast Media.......117
B. Market Analytics.......117
Table 27: US Recent Past, Current & Future Analysis for Imaging Agents by Product Segment – Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......117
1$350
   Table 28: US Historic Review for Imaging Agents by Product Segment - Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).......1181$350
   Table 29: US 11-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Dollar Sales for Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).......1191$350
  16. CANADA.......1204 $950  
   A. Market Analysis.......120
Outlook.......120
Diagnostic Equipment Market.......120
LOCM Products Approved in Canada.......120
1$100
   B. Market Analytics.......121
Table 30: Canadian Recent Past, Current & Future Analysis for Imaging Agents by Product Segment- Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......121
1$350
   Table 31: Canadian Historic Review for Imaging Agents by Product Segment - Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).......1221$350
   Table 32: Canadian 11-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Dollar Sales for Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).......1231$350
  17. JAPAN.......1244 $950  
   A. Market Analysis.......124
Outlook.......124
Reimbursement Issues.......124
1$100
   B. Market Analytics.......125
Table 33: Japanese Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......125
1$350
   Table 34: Japanese Historic Review for Imaging Agents by Product Segment - Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).......1261$350
   Table 35: Japanese 11-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Dollar Sales for Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).......1271$350
  18. EUROPE.......12810 $1995  
   A. Market Analysis.......128
Outlook.......128
Trends.......128
Reimbursement.......128
1$100
   Outsourcing of Imaging Diagnostics.......129
Distribution Structure.......129
Direct Sales.......129
License Agreements.......129
1$100
   Distribution Agreements.......130
A Price Sensitive Market.......130
Macro Environment.......130
Germany.......130
France.......130
1$100
   Spain & Italy.......131
Scandinavia.......131
1$100
   B. Market Analytics.......132
Table 36: European Recent Past, Current & Future Analysis for Imaging Agents by Geographic Region – France, Germany, UK, Italy, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......132
1$350
   Table 37: European Historic Review for Imaging Agents by Geographic Region – France, Germany, UK, Italy, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).......1331$350
   Table 38: European 11-Year Perspective for Imaging Agents by Geographic Region - Percentage Breakdown of Dollar Sales for France, Germany, UK, Italy, Spain, Russia and Rest of Europe Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).......1341$350
   Table 39: European Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......1351$350
   Table 40: European Historic Review for Imaging Agents by Product Segment - Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).......1361$350
   Table 41: European 11-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Dollar Sales for Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).......1371$350
  18a. FRANCE.......1383 $950  
   A. Market Analysis.......138
Outlook.......138
Growth Stimulants.......138
B. Market Analytics.......138
Table 42: French Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......138
1$350
   Table 43: French Historic Review for Imaging Agents by Product Segment - Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).......1391$350
   Table 44: French 11-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Dollar Sales for Contrast Media (X-ray, MRI and Ultrasound) & Diagnostic Radiopharmaceuticals Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).......1401$350
  18b. GERMANY.......1413 $950  
   A. Market Analysis.......141
Outlook.......141
B. Market Analytics.......141
Table 45: German Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......141
1$350
   Table 46: German Historic Review for Imaging Agents by Product Segment - Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).......1421$350
   Table 47: German 11-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Dollar Sales for Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).......1431$350
  18c. ITALY.......1443 $950  
   Market Analysis.......144
Table 48: Italian Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......144
1$350
   Table 49: Italian Historic Review for Imaging Agents by Product Segment - Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).......1451$350
   Table 50: Italian 11-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Dollar Sales for Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).......1461$350
  18d. THE UNITED KINGDOM.......1473 $950  
   A. Market Analysis.......147
Outlook.......147
B. Market Analytics.......147
Table 51: UK Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......147
1$350
   Table 52: UK Historic Review for Imaging Agents by Product Segment - Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).......1481$350
   Table 53: UK 11-Year Perspective for Imaging Agents by Product Segment Percentage Breakdown of Dollar Sales for Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).......1491$350
  18e. SPAIN.......1503 $950  
   Market Analysis.......150
Table 54: Spanish Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......150
1$350
   Table 55: Spanish Historic Review for Imaging Agents by Product Segment - Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).......1511$350
   Table 56: Spanish 11-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Dollar Sales for Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).......1521$350
  18f. RUSSIA.......1533 $950  
   Market Analysis.......153
Table 57: Russian Recent Past, Current & Future Analysis for Imaging Agents by Product Segment -Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......153
1$350
   Table 58: Russian Historic Review for Imaging Agents by Product Segment - Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).......1541$350
   Table 59: Russian 11-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Dollar Sales for Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).......1551$350
  18g. REST OF EUROPE.......1563 $950  
   Market Analysis.......156
Table 60: Rest of Europe Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......156
1$350
   Table 61: Rest of Europe Historic Review for Imaging Agents by Product Segment - Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).......1571$350
   Table 62: Rest of Europe 11-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Dollar Sales for Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).......1581$350
  19. ASIA-PACIFIC.......1594 $950  
   A. Market Analysis.......159
Outlook.......159
MRI Market in Asia.......159
ANSTO: Leading the Radiopharmaceuticals Market.......159
India – A High Potential Market.......159
1$100
   B. Market Analytics.......160
Table 63: Asia-Pacific Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......160
1$350
   Table 64: Asia-Pacific Historic Review for Imaging Agents by Product Segment - Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).......1611$350
   Table 65: Asia-Pacific 11-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Dollar Sales for Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).......1621$350
  20. THE MIDDLE EAST.......1633 $950  
   Market Analysis.......163
Table 66: Middle East Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......163
1$350
   Table 67: Middle East Historic Review for Imaging Agents by Product Segment - Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).......1641$350
   Table 68: Middle East 11-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Dollar Sales for Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).......1651$350
  21. LATIN AMERICA.......1663 $950  
   A. Market Analysis.......166
Private Sector Boosts Healthcare Segment.......166
B. Market Analytics.......166
Table 69: Latin American Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......166
1$350
   Table 70: Latin American Historic Review for Imaging Agents by Product Segment - Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).......1671$350
   Table 71: Latin American 11-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Dollar Sales for Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).......1681$350
COMPETITION 269$995
  
Total Companies Profiled: 55 (including Divisions/Subsidiaries - 71)

Region/Country                 Players


The United States                 37   
Canada                             3
Japan                              6
Europe                            19
     France                        2
     Germany                       6
     The United Kingdom            3
     Italy                         2
     Rest of Europe                6
Asia-Pacific (Excluding Japan)     5
Africa                             1
Click here to request a full table of contents and more details on this project.		  
 
 

© Global Industry Analysts, Inc., USA. All Rights Reserved.
Visa Master American Verisign